Cell Biology
| Name | Preis | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Research Grade Tozorakimab | Anmelden | Research Grade Tozorakimab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Licaminlimab | Anmelden | Research Grade Licaminlimab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Sibeprenlimab | Anmelden | Research Grade Sibeprenlimab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Dovanvetmab | Anmelden | Research Grade Dovanvetmab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Livmoniplimab | Anmelden | Research Grade Livmoniplimab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Anti-Human TGFa/TGF-alpha Antibody (LY3016859) | Anmelden | Research Grade Anti-Human TGFa/TGF-alpha Antibody (LY3016859) | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Anti-Human TGFB Antibody (XOMA 089) | Anmelden | Research Grade Anti-Human TGFB Antibody (XOMA 089) | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Anti-Human CD256/TNFSF13/APRIL (BION 1301) | Anmelden | Research Grade Anti-Human CD256/TNFSF13/APRIL (BION 1301) | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Atacicept | Anmelden | Research Grade Atacicept | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Baminercept Alfa | Anmelden | Research Grade Baminercept Alfa | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Efdamrofusp Alfa | Anmelden | Research Grade Efdamrofusp Alfa | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Eftozanermin Alfa | Anmelden | Research Grade Eftozanermin Alfa | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Lenercept | Anmelden | Research Grade Lenercept | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Opinercept | Anmelden | Research Grade Opinercept | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Tulinercept | Anmelden | Research Grade Tulinercept | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Anti-Human CD262/TNFRSF10B/TRAIL-R2/DR5 (TAS266) | Anmelden | Research Grade Anti-Human CD262/TNFRSF10B/TRAIL-R2/DR5 (TAS266) | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Anti-Human CD262/TNFRSF10B/TRAIL-R2/DR5 (LBY135) | Anmelden | Research Grade Anti-Human CD262/TNFRSF10B/TRAIL-R2/DR5 (LBY135) | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Anti-Human CD262/TNFRSF10B/TRAIL-R2/DR5 (DS-8273a) | Anmelden | Research Grade Anti-Human CD262/TNFRSF10B/TRAIL-R2/DR5 (DS-8273a) | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Anti-Human CD262/TNFRSF10B/TRAIL-R2/DR5 (IGM 8444) | Anmelden | Research Grade Anti-Human CD262/TNFRSF10B/TRAIL-R2/DR5 (IGM 8444) | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Anti-Human CD262/TNFRSF10B/TRAIL-R2/DR5 (INBRX-109) | Anmelden | Research Grade Anti-Human CD262/TNFRSF10B/TRAIL-R2/DR5 (INBRX-109) | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Anti-Human LGALS9 (HFB200902) | Anmelden | Research Grade Anti-Human LGALS9 (HFB200902) | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Anti-Human LGALS9 (HFB200901) | Anmelden | Research Grade Anti-Human LGALS9 (HFB200901) | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Anti-Human LGALS9 (LYT-200) | Anmelden | Research Grade Anti-Human LGALS9 (LYT-200) | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Infliximab | Anmelden | Research Grade Infliximab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Adalimumab | Anmelden | Research Grade Adalimumab | ||||||||||||||||
|
||||||||||||||||||


